Comerica Securities,Inc. Amgen Inc Transaction History

Comerica Securities,Inc.

$1.2 Billion
Q3 2023

A detailed history of Comerica Securities,Inc. transactions in Amgen Inc stock. As of the latest transaction made, Comerica Securities,Inc. holds 12,094 shares of AMGN stock, worth $3.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

12,094

Previous 13,006 7.01%

Holding current value

$3.2 Million

Previous $2.89 Million 12.57%

% of portfolio

0.27%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $199,408 - $247,571	-912 Reduced 7.01%	12,094 $3.25 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $201,413 - $238,167	940 Added 7.79%	13,006 $2.89 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $223,532 - $272,448	990 Added 8.94%	12,066 $2.92 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $114,744 - $145,796	-501 Reduced 4.33%	11,076 $2.91 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $96,293 - $108,601	429 Added 3.85%	11,577 $2.61 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $126,429 - $140,693	-548 Reduced 4.69%	11,148 $2.71 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $70,824 - $78,350	323 Added 2.84%	11,696 $2.83 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $102,423 - $117,214	-515 Reduced 4.33%	11,373 $2.56 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $695,184 - $814,492	-3,275 Reduced 21.6%	11,888 $2.53 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $275,390 - $305,526	-1,179 Reduced 7.21%	15,163 $3.7 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $195,280 - $227,568	-880 Reduced 5.11%	16,342 $4.07 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $142,594 - $169,804	659 Added 3.98%	17,222 $3.96 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $52,561 - $58,452	224 Added 1.37%	16,563 $4.21 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $262,493 - $322,115	1,327 Added 8.84%	16,339 $3.85 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $741,170 - $982,993	4,067 Added 37.16%	15,012 $3.04 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $71,899 - $92,416	380 Added 3.6%	10,945 $2.64 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $910,595 - $1.09 Million	-5,230 Reduced 33.11%	10,565 $2.04 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $1.03 Million - $1.24 Million	5,941 Added 60.29%	15,795 $3.08 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $1.25 Million - $1.47 Million	-7,519 Reduced 43.28%	9,854 $1.82 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $3.14 Million - $3.54 Million	17,373 New	17,373 $3.3 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.

Account

Comerica Securities,Inc. Amgen Inc Transaction History